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Excess dietary long-chain fatty acid (LCFA) intake results in ectopic lipid accumulation and insulin resistance. Since medium-chain fatty acids (MCFA) are
preferentially oxidized over LCFA, we hypothesized that diets rich in MCFA result in a lower ectopic lipid accumulation and insulin resistance compared to diets
rich in LCFA. Feeding mice high-fat (HF) (45% kcal fat) diets for 8 weeks rich in triacylglycerols composed of MCFA (HFMCT) or LCFA (HFLCT) revealed a
lower body weight gain in the HFMCT-fed mice. Indirect calorimetry revealed higher fat oxidation on HFMCT compared to HFLCT (0.011.0±0.0007 vs.
0.0096±0.0015 kcal/g body weight per hour, Pb.05). In line with this, neutral lipid immunohistochemistry revealed significantly lower lipid storage in skeletal
muscle (0.05±0.08 vs. 0.30±0.23 area%, P b.05) and in liver (0.9±0.4 vs. 6.4±0.8 area%, Pb.05) after HFMCT vs. HFLCT, while ectopic fat storage in low fat (LF)
was very low. Hyperinsulinemic euglycemic clamps revealed that the HFMCT and HFLCT resulted in severe whole body insulin resistance (glucose infusion rate:
53.1±6.8, 50.8±15.3 vs. 124.6±25.4 μmol min−1 kg−1, Pb.001 in HFMCT, HFLCT and LF-fed mice, respectively). However, under hyperinsulinemic conditions,
HFMCT revealed a lower endogenous glucose output (22.6±8.0 vs. 34.7±8.5 μmol min−1 kg−1, Pb.05) and a lower peripheral glucose disappearance
(75.7±7.8 vs. 93.4±12.4 μmol min−1 kg−1, Pb.03) compared to HFLCT-fed mice. In conclusion, both HF diets induced whole body insulin resistance
compared to LF. However, the HFMCT gained less weight, had less ectopic lipid accumulation, while peripheral insulin resistance was more pronounced
compared to HFLCT. This suggests that HF-diets rich in medium- versus long-chain triacylglycerols induce insulin resistance via distinct mechanisms.
© 2011 Elsevier Inc. All rights reserved.1. Introduction
Insulin resistance plays a key role in the pathogenesis of Type 2
diabetes mellitus and other metabolic disorders such as obesity and
hypertension [1]. Insulin resistance is characterized by the reducedAbbreviations: EGP, endogenous glucose production; HFLCT, high fat long-
chain triacylglycerol; HFMCT, high fat medum-chain triacylglycerol; LCFA,
long-chain fatty acid; LF, low fat; MCFA, medium-chain fatty acid; Rd, glucose
rate of disappearance.
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doi:10.1016/j.jnutbio.2010.03.004ability of insulin to promote peripheral glucose disposal and suppress
hepatic glucose output. It is currently believed that insulin resistance
is predominantly a life style disorder with diet composition as one of
the major determinants. Results from both epidemiological and
animal studies suggest that the risk of developing insulin resistance is
increased by consumption of a high-fat (HF) diet [2]. It is observed
that lipids not only increase body weight but also accumulate outside
the adipose depots in for example; muscle, liver and heart [3]. This
ectopic fat accumulation has been suggested to be directly or
indirectly responsible for an impaired insulin signaling and the
development of insulin resistance [4]. Indeed, multiple studies have
shown that mixtures of long chain fatty acids varying in the degree of
saturation originating from palm oil, lard, olive oil, corn oil or
safflower oil, negatively affect insulin sensitivity [5–8], paralleled by
an increase in ectopic fat accumulation [5,6].
Medium chain triacylglycerols are fats comprised of fatty acids
with a chain length of 6-12 carbons and found predominantly in
Table 2
Percentages of fatty acids in the diets
Percentage fatty acids of total lipids LF HFLCT HFMCT
%
C8:0 – – 37
C10:0 – – 55
C14:0 1 1 –
C16:0 16 75 1
C18:0 3 6 –
C18:1 19 13 2
C18:2 48 4 4
C18:3 5 1 1
Other 8 – –
All fatty acids are a percentage of total composition.
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differ in several aspects from long chain fatty acids; (a) their shorter
chain length renders them water-soluble in the intestinal lumen and
in the cytoplasm of target cells, (b) they are absorbed predominantly
via the portal vein into the liver bypassing the lymphatic system [9]
and (c) they are rapidly beta-oxidized [10] due to their independence
of mitochondrial carnitine palmitoyl transferase 1, which is a fatty
acid transporter and one of the rate limiting steps for mitochondrial
beta oxidation.
Several studies have confirmed an increased fat oxidation and
whole body energy expenditure in humans after 7–28 days diet
intervention with medium chain fatty acids [11,12]. Since MCFA are
preferentially oxidized, we questioned whether a HF diet rich in
medium chain fatty acids would lead to less accumulation of fat in the
skeletal muscle and the liver and thereby not impair insulin
sensitivity. Therefore, we here examined if long-term substitution
of medium chain triacylglycerols by long chain triacylglycerols in an
isocaloric diet with similar amounts of proteins, fat and carbohydrates
increases whole body fat oxidation and prevents long chain HF diet
induced and insulin resistance of skeletal muscle and liver.2. Materials and methods
2.1. Animals, diets and housing
Male C57bl/6J mice were obtained from Charles River Laboratories at an age of
8 weeks and acclimatized up to an age of 12 weeks at the Leiden University Medical
Centre animal facility. Animals were housed individually in a controlled environment
(23°C, 40–50% humidity) under a 12 h light-dark cycle (07:00-19:00). Food and tap
water was available ad libitum during the entire experiment. After acclimatization
mice were randomized and kept on a low-fat (LF) diet [13,14] (RM3, Special Diet
Services, Witham, Essex, UK) (Table 1), or a HF diet either rich in long-chain
triacylglycerol (HFLCT) or medium-chain triacylglycerols (HFMCT) (45% energy in the
form of fat, LCT; 4031.17, MCT; 4031.16, Hope Farms, Woerden, The Netherlands)
(Table 1). The fatty acid composition of the diets is shown in Table 2. All animal
experiments were approved by the Animal Ethic Committee from the Leiden University
Medical Center in accordance with the principles and guidelines established by the
European Convention for the Protection of Laboratory Animals.2.2. Indirect calorimetry
Groups of eight mice per HF diet were subjected to individual indirect
calorimetric measurements (Comprehensive Laboratory Animal Monitoring System,
Columbus Instruments, Columbus Ohio, US) for a period of 4 consecutive days after 1
and 8 weeks of diet intervention [36,37]. A period of 24 h was included at the start of
the experiment to allow acclimatization of the animals to the cages. This period was
not used in the calculation and interpretation of the results. Oxygen consumption
(VO2) and carbon dioxide production rates (VCO2) were measured at intervals of 7
minutes. Fat and carbohydrate oxidation rates were calculated from VO2 and VCO2
using the following formulas:
Carbohydrate oxidation ðkcal=hÞ = 4:5854VO2ð Þ− 3:2264VO2ð Þð Þ44ð Þ= 1000
Fat oxidation ðkcal=hÞ = 1:6954VO2ð Þ− 1:7014VO2ð Þð Þ49ð Þ= 1000
Total energy expenditure was calculated from the sum of carbohydrate and fat
oxidation. Measured parameters also included real time food intake and activity, which
was monitored as two-dimensional infrared beam breaks.Table 1
Macronutrient composition of the diets
Ingredients LF HFLCT HFMCT
g/kg
Protein 212 211 211
Carbohydrate 492 383 383
Fat 53 250 250
Fiber 46 61 61
MJ/kg
Energy 15.1 19.7 19.72.3. Net caloric intake
Feces were also collected during the stay in the metabolic cages in week 8. Feces
were lyophilized and analyzed for energy content using adiabatic bomb calorimetry
(Ikacalorimeter system C4000 Heitersheim, Germany). Net caloric intake by the animal
was calculated by subtraction of the energy content of the feces from the gross dietary
energy intake.
2.4. Histological analysis of intramyocellular and intrahepatic lipids
Cryosections (5 μm) from the liver and the midbelly region of the gastrocnemius
muscle were stained for neutral lipids with Oil red O [15] and quantified as previously
described [16].
2.5. Hyperinsulinemic euglycemic clamp
Hyperinsulinemic euglycemic clampswere performed as described before [17–21],
with minor modifications. Clamp experiments were performed after an overnight fast
and under anesthesia by intraperitoneal injection with a combination of Acepromazin
(0.5 mg/kg, Sanofi Santé Nutrition Animale, Libourne Cedex, France), Midazolam (0.25
mg/kg, Roche, Mijdrecht, The Netherlands) and Fentanyl (0.025 mg/kg, Janssen-Cilag,
Tilburg, The Netherlands).
A continuous infusion of D-[1-14C]glucose at a rate of 0.8 μCi/h (specific activity,
9.6 GBq/mmol; Amersham, Little Chalfont, UK) in the tail vein was started and blood
samples were taken to determine basal glucose kinetics. After 60 min, the mice
received a bolus of insulin (4.5 mU, Actrapid; Novo Nordisk, Chartres, France) to
initiate the hyperinsulinaemic state followed by constant infusion of insulin (3.5 mU/
kg per minute). Infusion of D-[1-14C]glucose was continued at a rate of 0.8 μCi/h and a
variable infusion of D-glucose (12.5% w/v in phosphate-buffered saline) was used to
maintain blood glucose levels at basal levels (euglycemia). Blood glucose was
monitored via tail bleeding with a hand glucose meter (AccuCheck, Roche Diagnostics,
Metronic Medical Systems, Vianen, The Netherlands) every 10 min to adjust the
glucose infusion rate. After reaching steady state, blood samples were taken at 10-min
intervals during 30 min to determine levels of D-[1-14C]glucose. An average clamp
experiment took approximately 2.5 h, and anesthesia as well as body temperature
was maintained throughout the procedure. Immediately after the last blood sample
the mice were killed by cervical dislocation and hindlimb skeletal muscles and liver
were dissected and frozen in liquid nitrogen-cooled isopentane and stored at −80°C
until further analyses.
2.6. Analysis of clamp samples
To measure plasma D-[1-14C]glucose activity, trichloroacetic acid (final concentra-
tion 2%) was added to 7.5 μl plasma to precipitate proteins using centrifugation. The
supernatant was dehydrated and resuspended in milliQ. The samples were counted
using scintillation counting (Packard Instruments, Dowers Grove, IL, USA).
2.7. Calculations
The glucose turnover rate (μmol min−1 kg−1) was calculated during the basal
period and under steady-state clamp conditions as the rate of tracer infusion (dpm/
min) divided by the plasma specific activity of D-[1-14C]glucose (dpm/μmol). This ratio
was corrected for total body mass. The hyperinsulinemic endogenous glucose
production was calculated as the difference between the tracer-derived rate of glucose
appearance and the glucose infusion rate.
2.8. Statistics
All data derived from the experiments were analyzed using the SPSS 15.0 package.
Indirect calorimetry and net caloric intake was tested using 2-sided unpaired t-tests for
normally distributed data. When comparing three groups analysis of variance
(ANOVA) was used to calculate for significant differences between groups and
Fig. 1. Respiratory exchange rate, substrate oxidation rates and total energy expenditure after 1 (A–D) or 8 weeks (E–H) on a HFMCT or HFLCT diet. RER (A and E), energy expenditure
(EE) (B and F) fat (C and G) and carbohydrate oxidation rates (D and H) are the mean values of the diurnal and nocturnal periods of the day (mean±S.D., n=8; *Pb.05 compared to the
respective diet in the same week).
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Fig. 2. Effects of an 8-week intervention with a LF, HFLCT or HFMCT diet on
intramyocellular lipid content of the hind limb skeletal muscle (A) and the intrahepatic
lipid content (B). Area fraction represents the percentage of the total muscle cell or
liver area covered by lipid droplets. (mean±S.D., n=3–8, bars with different letters are
significantly different, Pb.05).
Fig. 3. Effects of an 8-week intervention with a LF, HFLCT or HFMCT diet on glucose
infusion rate (GIR) during the hyperinsulinemic euglycemic clamp (mean±S.D.,
n=6–10, *Pb.001; LF vs HF).
369J. De Vogel-van den Bosch et al. / Journal of Nutritional Biochemistry 22 (2011) 366–371additional LSD post hoc tests to define the significance between groups. If ANOVA
assumptions were violated, the results were tested with non-parametric Kruskal-
Wallis ANOVA and Mann-Whitney U post hoc tests. All results are expressed as
means±S.D. Statistical significance threshold was set at Pb.05.
3. Results
3.1. Body weight and net caloric intake
Adult 12-week old male C57Bl/6 mice were maintained on a low-
fat (LF) diet or transferred to a HF diet, enriched in triacylglycerols
composed of long-chain fatty acids (HFLCT) or MCFAs (HFMCT) for a
period of 8 weeks. At the end of the study, all HF-fed mice gained
weight compared to the start of the experiment. After 8 weeks of diet
intervention, body weight gain of the HF-fed mice was significantly
higher compared to the LF-fed mice (Pb.02) (LF, 1.8±1.5 g; HFLCT,
5.6±1.4 g; HFMCT, 3.8±1.9). In addition, HFMCT mice gained
significantly less weight compared to the HFLCT fed mice (Pb.05).
Total caloric intake over 70 h, determined during the metabolic cage
analysis, was significantly lower in the HFMCT compared to HFLCT-
fed animals at Week 1 (HFMCT, 1.84±0.24 kcal/g; HFLCT, 3.11±0.49
kcal/g; Pb.01) and at Week 8 (HFMCT, 2.13±0.34 kcal/g; HFLCT,
2.80±0.48 kcal/g; Pb.05). Caloric content of the feces collected during
the stay in the metabolic cage in week 8 was significantly lower in the
HFMCT compared to the HFLCT-fed mice (HFMCT, 0.16±0.03 kcal/g;
HFLCT, 0.35±0.09 kcal/g; Pb.01), which represented ∼7.5% and
∼12.3% of total caloric intake. Despite the higher fecal caloric output
of the HFLCT-fed animals, net caloric intake was still significantly
higher in the HFLCT-fed animals compared to the HFMCT-fed mice
(HFLCT, 2.5±0.4 kcal/g; HFMCT, 2.0±0.3 kcal/g; Pb.02).
3.2. Indirect calorimetry
Indirect calorimetry measurements were applied to examine
whole body substrate utilization of the HF-fed mice during 3
consecutive days in Weeks 1 and 8. Total energy expenditure was
similar in both HF diets after one (P=1.0) or 8 weeks (P=.8) of
dietary intervention (Fig. 1A and E). However, mean 24-h respiratory
exchange rate (RER, defined as VCO2/VO2) in HFMCT-fed animals was
significantly lower compared to HFLCT-fed animals in week 1
(P=.05) (Fig. 1B). In week 8, 24 h RER values tended to be lower in
HFLCT-fed mice (P=.07) (Fig. 1F). These results indicate that HFMCT-
fed animals have a HF to carbohydrate oxidation ratio compared to
HFLCT-fed animals. Indeed, when calculating the 24 h fat and
carbohydrate oxidation levels, a higher 24 h fat oxidation rate was
found in HFMCT-fed mice in both week 1 (P=.03) and week
8 (P=.02) (Fig. 1C and G).
Calculated 24 h carbohydrate oxidation rates were not signifi-
cantly different between HFMCT and HFLCT-fed mice at week 1
(P=.07) or week 8 (P=.4) (Fig. 1D and H). These data indicate that
MCT feeding leads to higher relative and absolute fat oxidation levels
compared to LCT feeding.
3.3. Ectopic lipid accumulation
To determine whether HFMCT and HFLCT diets resulted in
differential ectopic lipid accumulation Oil red O staining of skeletal
muscle and liver was performed (Supplementary Figs. 1 and 2). These
experiments showed that the mice fed the HF diet enriched for MCT
had significantly lower levels of intramyocellular lipid content
compared to the HFLCT (Pb.03, Fig. 2A). Staining of liver sections
revealed a similar response with a significantly lower level of lipids in
the HFMCT group compared to the HFLCT group (Pb.002, Fig. 2B).
Intramyocellular and intrahepatic lipid content in the LF-fedmice was
very low and just above detection limits (Fig. 2A and B).3.4. Hyperinsulinemic-euglycemic clamp
To determine the effect of the HFMCT and HFLCT diets on whole-
body glucose metabolism, hyperinsulinemic euglycemic clamps were
performed in combination with continuous infusion of D-[14C]
glucose. From these experiments peripheral and liver insulin
sensitivity can be calculated separately. Glucose infusion rates to
maintain euglycemia during the clamp were not significantly
different between both HF diets (Fig. 3), but both infusion rates
were significantly lower compared to LF-fed mice (Pb.001 for both HF
groups vs. LF). Under basal conditions, glucose rate of disappearance
(Rd) and endogenous glucose production (EGP) were not significant-
ly different between groups (Fig. 4A and B).
Fig. 4. Basal and insulin stimulated glucose disappearance rate (Rd) (A) and
endogenous glucose production (EGP) (B) during the hyperinsulinemic euglycemic
clamp (mean±S.D., n=5–10, *Pb.05; HFLCT vs. LF and HFMCT; #Pb.005, HFMCT vs. LF
compared to the respective diet within the insulin stimulated state).
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the HFMCT-fed group compared to the HFLCT group (Pb.03).
Indicating impaired insulin sensitivity of the peripheral organs in
the HFMCT compared to the HFLCT-fed mice. In addition, insulin
stimulated Rd was significantly lower in both HF groups compared to
the LF group (Pb.005) (Fig. 4A).
In contrast, endogenous glucose production under hyperinsuline-
mic conditions was significantly lower— indicating improved hepatic
insulin sensitivity — in HFMCT compared to HFLCT (Pb.05). In
addition, EGP in the HFLCT was significantly higher compared to LF
(Pb.01) (Fig. 4B).
These results indicate that both HF diets induced insulin
resistance, although under hyperinsulinemic conditions peripheral
insulin sensitivity was more reduced by the HFMCT diet, whereas
liver insulin sensitivity was only affected by the HFLCT diet.4. Discussion
In the present study, we showed that diets rich in medium chain
triacylglycerols have much lower levels of lipids in skeletal muscle
and liver when compared to diets rich in long-chain triacylglycerols.
However, surprisingly, both HF diets reduced whole body insulin
sensitivity to a similar degree. Therefore, medium chain triacylgly-
cerol diets have no beneficial effect on themaintenance of whole body
glucose metabolism. Since there is a clear difference in the
development of tissue-specific insulin resistance, the mechanisms
underlying the development of insulin resistance may, however,
differ between long- and medium-chain diets.
Whole body insulin resistance is associated with increased
dietary fat intake [2,22]. Therefore, it would be an ideal strategy to
modulate whole body insulin sensitivity via a change in foodcomposition. In that context, MCT diets may be interesting. MCFAs
are preferentially oxidized compared to long-chain fatty acids
[10,23,24], first, due to their fast transport directly to the liver via
the portal vein [9,25,26]; second, MCFAs are directed towards
oxidation since fatty acyl synthetase responsible for triacylglycerol
re-esterification is most sensitive for FA with a chain length of 14 or
more [26] and third, because their transport into mitochondria is
predominantly carnitine-independent.
Since a disturbed balance in fat intake vs. oxidation has been
associated with the development of insulin resistance and Type 2
diabetes, foods that stimulate fat oxidation or inhibit food intake
would be expected to have beneficial effects on insulin sensitivity.
Here, we indeed show an acute and long-term adaptation with an
increased 24-h fat oxidation after a diet rich in medium chain
triacylglycerols when compared to LCT diets, as determined in whole
body metabolic cages. Furthermore, mice fed the HFMCT diet ate less
than the HFLCT-fed mice. This HFMCT- induced lower food intake
might be explained by the level of liver fatty acid oxidation. Friedman
et al. [27] have proposed that a decreased liver fatty acid oxidation,
which reduces hepatic energy production, stimulates feeding behav-
ior. In addition, it has been shown that increasing liver fatty acid
oxidation, with for example feeding medium chain triglycerides,
decreased food intake [28–30]. In addition, combining medium chain
triacylglycerols in a breakfast of healthy human volunteers also
decreased food intake by a post absorptive mechanism [31]. In the
current study, we observed a higher fatty acid oxidation in the HFMCT
compared to the HFLCT-fed mice. Although we do not know if the
observed high fatty acid oxidation is specific for the liver, the
peripheral tissues or both, we expect that due to the metabolic
properties of MCTs, fatty acid metabolism in the liver is at least
increased, which might explain the lower food intake in the HFMCT-
fed mice.
The increased fat oxidation in combination with the lower net
caloric intake of mice on the HFMCT diet compared to the HFLCT diet
might explain the lower body weight gain. In contrast to previous
reports [32,33], we did not observe any thermogenic effects of the
HFMCT diets, as 24 h energy expenditure was comparable between
HFLCT and HFMCT diets. More important, however, we confirmed our
hypothesis that HF diets rich inmedium chain fatty acids— in contrast
to diets with a similar energy fat percentage in the form of long chain
fatty acids — do not lead to the accumulation of lipids in skeletal
muscle and liver. However, unexpectedly, both diets induced similar
levels of whole body insulin resistance, when compared to LF diets.
This illustrates that an accumulation of fat in liver and/or skeletal
muscle is not a prerequisite for the development of whole-body
insulin resistance.
Insulin-stimulated disappearance of glucose was lower in the
HFMCT diet group when compared to the HFLCT diet group, whereas
hepatic insulin sensitivity was reduced in the HFLCT but not in the
HFMCT group. This indicates distinct regulation of the glucose
metabolism in peripheral insulin sensitive tissues and the liver after
both diets. In the HFLCT group, we speculate that whole body insulin
sensitivity is impaired due to the ectopic accumulation of lipids that
could interfere with insulin signaling in skeletal muscle and liver, as
suggested previously [4]. The absence of hepatic insulin resistance in
the HFMCT group fits with the concept that ectopic fat accumulation
is associated with the development of insulin resistance, as the
HFMCT diet, despite being high in fat content, did not result in the
accumulation of fat in the liver. Most likely, HFMCT-induced
peripheral insulin resistance is predominantly caused by a defect in
glucose uptake in the skeletal muscles, given that skeletal muscle
accounts for ∼75–80% [34] of all insulin-mediated glucose uptake in
the post prandial state. In that aspect, we can state that in the current
model the induction of skeletal muscle insulin resistance by the
HFMCT diet was not associatedwith accumulation of intramyocellular
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development of Type 2 diabetes mellitus has in recent years been
mainly explained by the accumulation of fatty acids in skeletal muscle
that could interfere with insulin signaling. Randle suggested three
decades ago [35] that competition of lipid substrates with glucose
could be responsible for the development of insulin resistance. The
results of the present study may fit with that concept. We observed a
higher rate of fat oxidation in the HFMCT compared to the HFLCT-fed
mice at all time points measured. We speculate that this high fatty
acid oxidation rate in HFMCT-fed animals is due to a higher fat
oxidation rate in the liver and skeletal muscles. Medium chain
triacylglycerols are rapidly available and preferentially oxidized
compared to LCT [10,23,24]. The reduced peripheral uptake of glucose
might be due to the contribution of the myocellular MCFA-derived
acetyl-CoA to the total pool of acetyl-CoA, which could create a
negative feedback loop via citrate accumulation on pyruvate
dehydrogenase. This sequentially blocks the glycolytic pathway and
ultimately results in reduced glucose uptake and oxidation and
thereby to a reduced insulin stimulated uptake of glucose [35].
However, further exploration of these substrate fluxes requires
additional studies.
Taken together, a HF diet rich in medium chain triacylglycerols is
preferentially oxidized over long chain triacylglycerols, which
resulted in a lower accumulation of lipids in the skeletal muscle and
the liver of the mice. Surprisingly, both HF diets induced whole body
insulin resistance, although the HFMCT had a lower peripheral insulin
sensitivity and normal hepatic insulin sensitivity compared to the
HFLCT-fed mice. This suggests that these diets induce insulin
resistance via distinct mechanisms.Appendix A. Supplementary data
Supplementary data associated with this article can be found, in
the online version, at doi:10.1016/j.jnutbio.2010.03.004.References
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